Johns Hopkins Joins Cancer AI Alliance
Harnessing the power of artificial intelligence (AI) will enable new strategies for tackling cancer in a collaborative venture that brings together team science and vast ...
Read moreIf you're an HR or benefits professional seeking cancer resources for your employees, or a consultant looking to provide best-in-class cancer support for your clients, share a few details below. We’ll reach out to help your company get started.
If you’re an employee looking for your AccessHope benefit, call 800.423.3232 and select Option 1.
Harnessing the power of artificial intelligence (AI) will enable new strategies for tackling cancer in a collaborative venture that brings together team science and vast ...
Read moreDana-Farber researchers have uncovered an alarming reality: children from low-income households are more likely to experience cancer relapse and face lower survival rates compared to their more ...
Read moreA study conducted by executive director of Winship Cancer Institute of Emory University, found a new drug that shows remarkable promise in treating patients with a specific type of advanced lung ...
Read moreIn a first-of-its-kind study, Northwestern Medicine researchers sought cancer patients’ input on how they want to be screened for financial needs.The study revealed that cancer patients want ...
Read moreA study led by researchers at UT Southwestern Medical Center reveals significant disparities across the country in the use of immunotherapy for patients with advanced kidney and bladder cancers. ...
Read moreScientists from City of Hope, an AccessHope foundational partner, have cornered the culprit that helps cancer cells evade CAR T cell therapy.
Read moreAs
Read moreCity of Hope’s Idoroenyi Amanam, M.D. is getting noticed for his abilities, ...
Read moreTreatments for medical conditions like cancer and heart disease can leave lasting physical and mental scars. Research showed that 58% of people who underwent treatment for cancer had a negative ...
Read moreAccording to City of Hope's Stephen Gruber, M.D., M.P.H., precision medicine has led to the greatest progress in cancer medicine that we’ve yet seen. By leveraging the genetic and genomic features ...
Read more